Remacemide versus carbamazepine in newly diagnosed epilepsy

Epilepsy and Behavior

Volumn 3, Issue 4, 2002, Pages 405-406

  Whitehead, John ^a   Stevens, John ^a   Brodie, Martin ^a   Wroe, Stephen ^a   Dean, Andrew ^a   Holdich, Thomas ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; REMACEMIDE;

CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EPILEPSY; HUMAN; LETTER; LICENSING; PUBLISHING; SAMPLE SIZE; SEQUENTIAL ANALYSIS; TREATMENT OUTCOME;

EID: 0036669408     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-5050(02)00044-6     Document Type: Editorial

References (3)

1. Brodie MJ, Wroe SJ, Dean ADP, Holdich TAH, Whitehead J, Stevens J. Efficacy and safety of remacemide versus carbamazepine in newly diagnosed epilepsy: comparison by sequential analysis. Epilepsy Behav 2002;3:140-6.
2. Beydoun A. Sequential design studies for antiepileptic drugs. Epilepsy Behav 2002;3:107-8.
3. French JA. Active-control antiepileptic drug trials in the newly diagnosed patient: are we getting closer?. Epilepsy Behav 2002;3:109-12.